When was Nevro founded?

Nevro was founded in 2006 and raised its 1st funding round within a year of its incorporation.

Where is Nevro located?

Nevro is headquartered in Menlo Park, United States. It is registered at Redwood City, California.

How many employees does Nevro have?

As of Sep 30, 2026, the latest employee count at Nevro is 892.

Is Nevro a funded company?

Nevro is a funded company, having raised a total of $154M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 04, 2006.

How much is Nevro worth?

The last known valuation of Nevro was $***** as of Feb 06, 2025.

When was the latest funding round of Nevro?

Nevro's latest funding was a $***** Post IPO round on Apr 10, 2020, with participation from 0 investor.

What is the annual revenue of Nevro?

Annual revenue of Nevro is between $100M and $500M as on Dec 31, 2024

Where does Nevro rank among its competitors?

Nevro ranks 8th amongst 396 active competitors, of which 97 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was WISE, which secured $34.8M in Jun, 2026.

Who are the top competitors of Nevro?

Nevro's top competitors include MicroTransponder, ATEC Spine and Perfuze. Among them, WISE secured the most recent funding round in June, 2026.

Nevro - 2026 Company Profile, Funding, Competitors & Financials

Q: Is Nevro an acquired company?

Nevro got acquired by Globus Medical on Feb 06, 2025.

Company Details

Provider of high-frequency spinal cord stimulation implants. The Senza SCS system features Nevro’s high-frequency stimulation technology for spinal cord stimulation.

Website: www.nevro.com/
Social
Registered Address: Redwood City, California

Key Metrics

Founded Year

2006

Location

Menlo Park, United States

Stage

Acquired

Total Funding

$154M in 8 rounds

Latest Funding Round

Post IPO, Apr 10, 2020, $*****

Last Known Valuation

$***** as on Feb 06, 2025

Investors

Aberdare Ventures & 11 more

Ranked

8^th among 396 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2024

Employee Count

892 as on Sep 30, 2026

Investment & Acquisitions

VYRSA Technologies

Similar Companies

ATEC Spine & 344 more

Exit Details

Acquired by Globus Medical (Feb 06, 2025)

View Nevro's full profile

Nevro is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Nevro Corp CIN: 1444380 , United States, Active		$100M - $500M (As on Dec 31, 2024)	-	-
NEVRO CORP CIN: 562568057 , United States, Active	Dec 31, 1999	-	826 (As on Dec 31, 2024)	-

Nevro got acquired by Globus Medical on Feb 06, 2025 at an acquisition amount of $*****.

Click here to take a look at Nevro's acquisition in detail

Nevro has raised a total funding of $154M over 8 rounds. Its first funding round was on Dec 04, 2006. Nevro has 12 institutional investors.

Here is the list of recent funding rounds of Nevro:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 10, 2020	2060127	Post IPO	1127743	2688601	1406384	9122439
Jun 2016	5440107	Post IPO	7611447	3295381	2123553	2196057
Dec 15, 2014	2493761	Conventional Debt	7795345	3382885	7339384	CRG

Access funding benchmarks and valuations. Sign up today!

View details of Nevro's funding rounds and investors

Nevro's employee count trend

Nevro has 892 employees as of Sep 26. Here is Nevro's employee count trend over the years:

Uncover Nevro's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nevro include MicroTransponder, ATEC Spine and Perfuze. Here is the list of Top 10 competitors of Nevro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	MicroTransponder 2007, Dallas (United States), Series F	Developer of neuromodulation therapy for neurological conditions	$180M	USVP, Green Park & Golf Ventures & 11 others	65/100
2nd	ATEC Spine 1990, San Diego (United States), Public	Developer of treatment solutions for spine disorders	-	Perceptive Advisors, Armistice Capital & 12 others	64/100
3rd	Perfuze 2018, Galway (Ireland), Series A	Developer of a medical device for the treatment of acute ischemic stroke	$53.2M	Earlybird, Seroba Lifesciences & 7 others	64/100
4th	Paradigm Spine 2005, New York City (United States), Acquired	Manufacturer of stabilization devices for the healthcare industry	$142M	Athyrium Capital Management, HealthCor Partners ... & 6 others	63/100
5th	Si-Bone 2008, San Jose (United States), Public	Titanium implant fixation system	$103M	Skyline Ventures, Arboretum Ventures & 10 others	62/100
6th	Xtant Medical Holdings 2006, Belgrade (United States), Public	Manufacturer of orthobiologic products and spinal fixation implant medical systems	$11M	Orbimed, Military Health & 1 others	62/100
7th	MiRus 2015, Marietta (United States), Series D	Developer of rhenium-based implants for spine surgeries	$1.56B	Mammoth, Boston Scientific	62/100
8th	Nevro 2006, Menlo Park (United States), Acquired	Provider of high-frequency spinal cord stimulation implants	$154M	Medtronic, CRG & 10 others	62/100
9th	Spineart 2005, Plan les Ouates (Switzerland), Series B	Manufacturer of spinal implants and robotic systems for surgical procedures	$139M	EGS Beteiligungen, Gimv & 1 others	61/100
10th	WISE 2011, Milan (Italy), Series D	Provider of solutions for neuromodulation and neuromonitoring	$91.4M	Principia SGR, CDP Venture Capital & 12 others	60/100